Denmark· DK-28104042806
Torisel
A temsirolimus product containing temsirolimus, registered in Denmark by Pfizer Europe MA EEIG. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Temsirolimus is registered in 10 of 19 countries.
Countries holding a registration under ATC L01EG01 (temsirolimus), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Temsirolimus · ATC L01EG01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Temsirolimus
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Denmark (DK)
- ATC code
- L01EG01
- ATC class
- Temsirolimus
- Defined daily dose
- 3.57 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104042806
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
596 interactions on record for temsirolimus.
Graded by severity as the source publishes them — 168 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Temsirolimus · interactions on record
596 records
- 168 severe
- 419 moderate
- 9 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Amphotericin BA07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01EG01
Temsirolimus, as other registers publish it.
- BelgiumTemsirolimus Accord 30 mgAccord Healthcare
- FinlandToriselPfizer Europe MA EEIG
- PolandToriselPfizer Europe MA EEIG
- IcelandToriselPfizer Europe MA EEIG*
- CzechiaTORISELPfizer Europe MA EEIG, Bruxelles
- CanadaTORISELPFIZER CANADA ULC
- NetherlandsTorisel 25 mg/ml, concentraat voor oplossing voor infusiePfizer Europe MA EEIG
- BelgiumTorisel 30 mgPfizer Europe MA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/21c2fd3a-f754-434b-be81-26c51f30cdda GET /v1/drugs/21c2fd3a-f754-434b-be81-26c51f30cdda?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat og solvens til infusionsvæske, opløsning",
"source": "dkma",
"strength": "30 mg",
"auth_role": "MOD",
"dk_drugid": "28104042806",
"substance": "Temsirolimus",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "39405"
}See everything about temsirolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.